EISSN 2475-0581
IMPACT FACTOR:
0.6
INDEXED IN
SCI EXPANDED
INDEXED IN
PUBMED
Psychiatry and Clinical Psychopharmacology
Toggle navigation
ABOUT
ARCHIVE
EDITORIAL BOARD
POLICIES
FOR AUTHORS
CONTACT
IMPACT FACTOR:
0.6
INDEXED IN
SCI EXPANDED
INDEXED IN
PUBMED
Psychiatry and Clinical Psychopharmacology
PDF
HIGHLY CITED ARTICLES
Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria
Danışman et al.
Association Between Mood Disorder Severity, Treatment Response and Systemic Inflammatory Markers: Exploring the Role of NLR, PLR, MLR, and SII
Kucukkarapınar et al.
Experiential Avoidance Process Model: A Review of the Mechanism for the Generation and Maintenance of Avoidance Behavior
Wang et al.
Home
Vancouver biomedikal süreli ya...
Vancouver biomedikal süreli yayınlara yollanan yazılar için yeni tek tip kuralları
Erdem TOĞROL
1
Author Affiliation(s)
1.
Nöroloji Uzmanı, GATA Haydarpaşa Eğıtım Hastanesi
Psychiatry and Clinical Psychopharmacology
1996; 6: 69-78
Read: 25
Downloads: 13
Published: 01 March 1996
Volume 6, Issue 1, March 1996
Previous Article
Next Article
Menu
Search
Full Text PDF
Latest Issue
Archive
Advanced Search
Search
SHARE
Files
Full Text PDF
EISSN
2475-0581
MANUSCRIPT SUBMISSION
SEARCH
ABOUT
ARCHIVE
EDITORIAL BOARD
POLICIES
FOR AUTHORS
CONTACT
×
Send To Friend
Email
Loading...
Submit
×
Full Text PDF
/Content/files/sayilar/114/6_1_10.pdf
.png)
.png)